Factors associated with attendance at clinical follow-up of a cohort with screen-detected type 2 diabetes:ADDITION-Denmark
Autor: | Morten Charles, Daniel R. Witte, Annelli Sandbæk, Lasse Bjerg, Else Marie Dalsgaard, Marit E. Jørgensen, Signe T Andersen, Annette Danielsen Jensen, Bibi Gram |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Endocrinology Diabetes and Metabolism Denmark 030209 endocrinology & metabolism Disease Type 2 diabetes Comorbidity Follow-up studies Logistic regression 03 medical and health sciences 0302 clinical medicine Diabetes mellitus type 2 Risk Factors Diabetes mellitus Internal medicine Internal Medicine Medicine Humans Mass Screening 030212 general & internal medicine Aged Retrospective Studies Nutrition and Dietetics Primary Health Care business.industry Incidence Attendance Cancer Middle Aged medicine.disease Diabetes Mellitus Type 2 Cardiovascular Diseases Cohort Female Family Practice business Follow-Up Studies |
Zdroj: | Jensen, A D, Andersen, S T, Charles, M, Bjerg, L, Witte, D R, Gram, B, Jørgensen, M E, Sandbæk, A & Dalsgaard, E M 2020, ' Factors associated with attendance at clinical follow-up of a cohort with screen-detected type 2 diabetes : ADDITION-Denmark ', Primary Care Diabetes, vol. 14, no. 3, pp. 239-245 . https://doi.org/10.1016/j.pcd.2019.09.001 |
Popis: | Aims: To determine the association between concurrent overall burden of disease, cardiovascular disease, cancer, self-rated health, HbA1c levels, and attendance at clinical follow-up of the Danish arm of the ADDITION-study. Methods: Logistic regression models were used to study factors proposed being associated with attendance in clinical follow-up. We used data from clinical examinations, questionnaires and national registers at a time-point near the follow-up examination. Results: A total of 1119 participants were eligible for the follow-up conducted a median of 12.8 years (IQR 11.6; 13.4) after type 2 diabetes diagnosis by screening. Concurrent high burden of disease was associated with lower attendance (OR 0.6 (95% CI: 0.4; 0.9) for high-versus no burden of disease). Concurrent cardiovascular disease and cancer showed no statistically significant association with attendance (OR 1.0 (95% CI: 0.7; 1.4)) and (OR 0.8 (95% CI: 0.6; 1.1) for (disease versus no disease). Similarly, self-rated health (OR 0.7 (95% CI: 0.5; 1.0) poor-versus good self-rated health) and HbA1c levels (OR 1.0 (95% CI: 0.9; 1.2 unit = 10 mmol/mol)) were not statistically significant associated with attendance. Conclusions: This study showed a lower attendance in clinical follow-up after nearly 13 years among individuals with concurrent high burden of disease. No associations were found between concurrent CVD, cancer, self-rated health and Hba1c levels and attendance. |
Databáze: | OpenAIRE |
Externí odkaz: |